The levels of LDH and IL-1β release into the culture medium of CD4+ T cells from RA patients were decreased after ERAP2-knockdown by approximately 20% and 40%, respectively, relative to controls (Fig. 2F, I). The gene discussed is CD4; the disease is rheumatoid arthritis.